Gene Therapy for Mesothelioma

OncoLink Team
The Abramson Cancer Center of the University of Pennsylvania
Last Modified: May 7, 2013

Share article


What results are you seeing in using gene therapy to treat mesothelioma?


Dan Sterman, MD, Interventional Pulmonologist at Penn Medicine, responds:

The results of gene therapy trials for mesothelioma to date (from 1995 to the present) have shown that the delivery methods are safe, that we can get expression of the therapeutic genes within the tumor cells, and that we can induce some anti-tumor responses. The trials to date, however, have all been in the Phase I trials. Therefore, response rates, increases in survival, and other crucial questions still will await final analysis of current Phase II and future Phase III clinical trials.

You may be interested in Dr. Sterman's presentation about gene therapy for mesothelioma at the 2012 Focus on Mesothelioma conference.

This question and answer was part of the OncoLink Brown Bag Chat Series. View the entire Focus on Mesothelioma transcript.

I Wish You Knew

What is Photodynamic Therapy and how is it used in cancer care?

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More